Hamburg, Germany

Sheraz Gul

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: International Society for Drug Development S.r.l.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sheraz Gul. Retrieved from https://idiyas.com/inventor/sheraz-gul-o6f7l1it

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sheraz Gul: Innovator in Thyromimetics

Introduction

Sheraz Gul is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with thyroid hormone receptors.

Latest Patents

Sheraz Gul holds a patent for "Thyromimetics with a biphenylmethane scaffold and their use." This invention concerns a compound of Formula (I) or a salt thereof, which can be utilized in the treatment of diseases modulated by thyroid hormone receptor-beta (TRβ). The compound's structure includes various functional groups that enhance its therapeutic potential.

Career Highlights

Throughout his career, Sheraz Gul has worked with several organizations, including the International Society for Drug Development and Purytra Farmaceutici. His work has focused on innovative drug development and the exploration of new therapeutic avenues.

Collaborations

Sheraz has collaborated with notable professionals in the field, including Guido Puricelli and Simona Rapposelli. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Sheraz Gul's work in the field of thyromimetics showcases his innovative spirit and dedication to improving healthcare through scientific advancements. His contributions are paving the way for new treatments that could significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…